Liver fibrosis: New insights into migration of activated hepatic stellate cells

被引：0
|
作者：
Yang, CQ
Zeisberg, M
Mosterman, B
Sudhakar, A
Yerramalla, U
Afdhal, N
Kalluri, R
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M845
引用
收藏
页码：A653 / A653
页数：1
相关论文
共 50 条
  • [21] Hepatic stellate cells as a target for the treatment of liver fibrosis
    Bataller, R
    Brenner, DA
    SEMINARS IN LIVER DISEASE, 2001, 21 (03) : 437 - 451
  • [22] Hepatic stellate cells: a target for the treatment of liver fibrosis
    Wu, J
    Zern, MA
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (09) : 665 - 672
  • [23] Senescence of activated stellate cells limits liver fibrosis
    Krizhanovsky, Valery
    Yon, Monica
    Dickins, Ross A.
    Hearn, Stephen
    Simon, Janelle
    Miething, Cornelius
    Yee, Herman
    Zender, Lars
    Lowe, Scott W.
    CELL, 2008, 134 (04) : 657 - 667
  • [24] Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
    Li, D
    Friedman, SL
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (07) : 618 - 633
  • [25] Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
    Ezhilarasan, Devaraj
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (01) : 436 - 449
  • [26] Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
    Park, Yong Joo
    An, Hyoung-Tae
    Park, Jong-Sung
    Park, Ogyi
    Duh, Alexander J.
    Kim, Kwangmeyung
    Chung, Kyu Hyuck
    Lee, Kang Choon
    Oh, Yumin
    Lee, Seulki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
    Yong Joo Park
    Hyoung-Tae An
    Jong-Sung Park
    Ogyi Park
    Alexander J. Duh
    Kwangmeyung Kim
    Kyu Hyuck Chung
    Kang Choon Lee
    Yumin Oh
    Seulki Lee
    Scientific Reports, 10
  • [28] An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
    Li, Yanping
    Pu, Shiyun
    Liu, Qinhui
    Li, Rui
    Zhang, Jinhang
    Wu, Tong
    Chen, Lei
    Li, Hong
    Yang, Xuping
    Zou, Min
    Xiao, Jia
    Xie, Wen
    He, Jinhan
    JOURNAL OF CONTROLLED RELEASE, 2019, 303 : 77 - 90
  • [29] Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis
    Younis, Mahmoud A.
    Sato, Yusuke
    Elewa, Yaser H. A.
    Kon, Yasuhiro
    Harashima, Hideyoshi
    JOURNAL OF CONTROLLED RELEASE, 2023, 353 : 685 - 698
  • [30] Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells
    Xia, Shenglong
    Liu, Zimo
    Cai, Jieru
    Ren, Huiming
    Li, Qi
    Zhang, Hongfang
    Yue, Jing
    Zhou, Quan
    Zhou, Tianhua
    Wang, Liangjing
    Liu, Xiangrui
    Zhou, Xuefei
    JOURNAL OF CONTROLLED RELEASE, 2023, 355 : 54 - 67
12345